Stock Market Today: Dow, S&P 500, Nasdaq Rebound as Treasury Bond Buyback Calms Investors – August 20, 2026

Stock Market Today: Dow, S&P 500, Nasdaq Rebound as Treasury Bond Buyback Calms Investors – August 20, 2026

Stock Market Today: Dow, S&P 500, Nasdaq Rebound as Treasury Bond Buyback Calms Investors – August 20, 2026

U.S. Markets Close Higher After Treasury Intervention

U.S. equities finished Thursday in positive territory, with all three major indexes erasing earlier losses to post modest gains. The rebound marked a sharp reversal from the previous three sessions, as a coordinated move by the Treasury Department to buy back long-term bonds injected fresh confidence into the market.

By the closing bell at 4:00 p.m. Eastern Time, the S&P 500 had risen 0.21%, or 16.22 points, to settle at 7,707.98. The Dow Jones Industrial Average gained 119.65 points, or 0.22%, closing at 53,463.05, while the Nasdaq Composite advanced 0.16%, or 41.38 points, to end the day at 26,331.09.

Key Takeaway: The Treasury Department doubled its buyback limit for 10- to 30-year bonds, driving long-term yields sharply lower and providing a tailwind for rate-sensitive growth stocks.


Why Did the Stock Market Rally Today?

The session’s primary catalyst was the Treasury’s aggressive bond repurchase plan, which effectively absorbed supply and pushed down yields on longer-dated government debt. Lower yields typically boost stock valuations, particularly for technology and growth companies that rely on future cash flows.

However, gains were trimmed after the release of the Federal Reserve’s July meeting minutes, which revealed that multiple officials supported further interest rate hikes if inflation proves stubborn. The minutes served as a hawkish reminder that the central bank remains vigilant, preventing a more robust rally.


Biggest Stock Movers: Winners and Losers

Top Gainers

  • Moderna (MRNA): Soared nearly 180% after announcing positive Phase 3 trial results for its personalized mRNA cancer vaccine, developed in partnership with Merck. The breakthrough marks the first successful late-stage trial for an mRNA-based cancer therapy.
  • Merck (MRK): Climbed nearly 13% , making it the best-performing stock in the Dow today, riding the coattails of Moderna’s success.
  • Deere & Company (DE): Jumped 9% after beating fiscal third-quarter earnings expectations, reporting $5.10 per share on $11 billion in revenue.
  • Coinbase (COIN) & Strategy: Each gained roughly 8% as Bitcoin reclaimed the $70,000 level following President Trump’s endorsement of cryptocurrency legislation.
  • Mara Holdings (MARA): Surged 12% alongside the broader crypto rally.

Top Losers

  • Walmart (WMT): Tumbled 8% after reporting weaker-than-expected U.S. comparable store sales growth of just 2.6%, missing the 3.5% consensus estimate. Despite raising its full-year guidance, investors worried about softening consumer spending on discretionary goods.

Sector Performance: Tech and Consumer Discretionary Lead

Technology and consumer discretionary sectors outperformed, fueled by the drop in bond yields. The Magnificent Seven stocks mostly advanced, with Tesla (TSLA) rising over 4% and Amazon (AMZN) and Apple (AAPL) each gaining more than 2%. Nvidia (NVDA) bucked the trend with a modest decline.

Retail and consumer staples lagged, dragged down by Walmart’s disappointing results, which reignited concerns about the health of the U.S. consumer heading into the final quarter of the year.


What Investors Should Watch Next

  • Inflation Data: The Fed’s next policy move hinges on upcoming inflation reports. Any signs of reaccelerating prices could trigger another rate hike.
  • Treasury Buyback Program: Continued support from the Treasury may keep yields in check, but the program’s long-term effectiveness remains uncertain.
  • Consumer Spending Trends: With Walmart signaling caution, upcoming earnings from other major retailers will be critical in gauging consumer strength.

Final Thoughts

Today’s rebound provided a much-needed respite for investors after three consecutive down days. The Treasury’s intervention successfully calmed bond market jitters, while Moderna’s historic cancer vaccine breakthrough offered a glimpse of transformative medical innovation.

Still, the Fed’s hawkish undercurrent and Walmart’s consumer warning serve as cautionary tales. As we head into the final months of 2026, the market’s trajectory will likely depend on the delicate balance between inflation, interest rates, and consumer resilience.


Market Hours Reminder: Regular trading resumes tomorrow at 9:30 a.m. ET. Pre-market trading begins as early as 4:00 a.m. ET.


Disclaimer

This article is for informational and educational purposes only and does not constitute financial advice, investment recommendations, or an endorsement of any security, strategy, or account type. All market data and analysis are based on publicly available sources and are believed to be accurate at the time of writing, but accuracy is not guaranteed. Past performance does not guarantee future results. Investing involves risk, including the possible loss of principal. You should consult with a qualified financial professional before making any investment decisions. The author and publisher are not responsible for any financial losses or gains incurred as a result of this content. Read our full editorial policy for more details.